Patent · US Expired

Matriptase inhibitors and methods of use

US7019019B2 · kind B2 · utility

4Cited by
20References
42Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2003
Grant dateMar 28, 2006
Priority date
Expiry dateFeb 20, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D333/38
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides matriptase inhibitors and compositions thereof useful for treating cancer. Martripase is a trypsin-like serine protease active in the development of cancerous conditions, such as tumors and metastasis of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.